Unitat Atenció Crohn-Colitis, Digestive System Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Vall d'Hebron Institute of Research, Physiology and Digestive Physiopathology Research Group, Centro de Investigación Biomédica en Red en el Área Tematica de Enfermedades Hepáticas, Barcelona, Spain.
Inflamm Bowel Dis. 2023 Sep 1;29(9):1362-1369. doi: 10.1093/ibd/izad058.
Microbiome studies report low gut microbial richness and diversity in ulcerative colitis (UC) patients. We explored whether UC patients who reach long-term clinical, endoscopic, and histological remission show a gut microbial ecosystem that is similar to healthy individuals.
We collected 184 stool samples from 111 individuals (UC patients in long remission, short remission, flare, and healthy control subjects). Microbiota was analyzed by amplicon sequencing (16S ribosomal RNA) and quantitative polymerase chain reaction for specific taxa. All UC remission patients were followed-up for 2 years.
A drop in species diversity and richness, underrepresentation of butyrate producers, and gain of potentially harmful bacteria were significantly detected in samples from disease-flare and short-remission patients. In contrast, Chao1 and Shannon indexes of diversity did not differ among patients in long remission and healthy control subjects. Long-remission patients also presented fecal bacterial composition closer to that in healthy control subjects. There was a positive correlation between Akkermansia muciniphila abundance and time in remission (rs = 0.53, P < .001). Logistic regression analysis showed that a high Shannon index (odds ratio, 4.83; 95% confidence interval, 1.5-20.6) or presence of A. muciniphila (odds ratio, 4.9; 95% confidence interval, 1.12-29.08) in fecal samples at entry was independently associated with clinical remission over a follow-up period of 24 months.
UC patients who achieve long-term remission show evidence of substantial recovery of the gut microbial ecosystem in terms of diversity and composition. Recovery may just reflect adequate control of inflammatory activity, but higher bacterial diversity or the presence of A. muciniphila in fecal samples predicts flare-free outcomes.
微生物组研究报告溃疡性结肠炎(UC)患者的肠道微生物丰富度和多样性较低。我们探讨了达到长期临床、内镜和组织学缓解的 UC 患者是否表现出类似于健康个体的肠道微生物生态系统。
我们收集了 111 名个体(长期缓解、短期缓解、发作和健康对照个体)的 184 份粪便样本。通过扩增子测序(16S 核糖体 RNA)和特定分类群的定量聚合酶链反应分析微生物群。所有 UC 缓解患者均随访 2 年。
在疾病发作和短期缓解患者的样本中,显著检测到物种多样性和丰富度下降、丁酸盐产生菌代表性降低以及潜在有害细菌增加。相比之下,长期缓解患者和健康对照个体的 Chao1 和 Shannon 多样性指数无差异。长期缓解患者的粪便细菌组成也更接近健康对照个体。Akkermansia muciniphila 丰度与缓解时间呈正相关(rs=0.53,P<0.001)。逻辑回归分析显示,粪便样本中高 Shannon 指数(优势比,4.83;95%置信区间,1.5-20.6)或存在 A. muciniphila(优势比,4.9;95%置信区间,1.12-29.08)与 24 个月随访期间的临床缓解独立相关。
达到长期缓解的 UC 患者在多样性和组成方面表现出肠道微生物生态系统实质性恢复的证据。恢复可能只是反映了炎症活动的充分控制,但粪便样本中较高的细菌多样性或 A. muciniphila 的存在可预测无发作结局。